Antibiotics do not reduce the risk of hospitalization or death in patients with a lethal lung disease known as idiopathic pulmonary fibrosis, a new study finds. “We were certainly disappointed in the results,” said study co-author Dr. Imre Noth, chief of pulmonary and critical care medicine at UVA Health in Charlottesville, Va. “But we remain… read on > read on >
It has been an elusive goal so far — finding a potent treatment that can beat back the new coronavirus before it grabs a hold of a patient’s immune system and sends it into overdrive. But new research suggests that more than a dozen existing drugs or drugs under development may do the trick. Investigators… read on > read on >
The risk of death after a traumatic brain injury is twice as high among people of color as it is among whites, a new study finds. Oregon Health & Science University (OHSU) researchers reviewed outcomes among more than 6,300 traumatic brain injury patients treated at the university’s hospital between 2006 and 2017. The overall death… read on > read on >
If it’s been a while since you’ve seen your doctor, it may be time to schedule a visit to catch up on preventive health screenings or discuss any health concerns and chronic medical conditions. During the 15 months since people began quarantining, many have avoided leaving their homes except when necessary, including not going to… read on > read on >
As you seek to cool down in a pool or at the beach this summer, always keep water safety for yourself and others in mind, an expert urges. “With children, I always recommend starting swim lessons at an early age and having parents put on floaties or life vests on their children when near any… read on > read on >
FRIDAY, June 4, 2021 (American Heart Association News) — When Arthur Castro was born, doctors could immediately tell something was wrong. The color of his skin belied trouble with his heart that hadn’t been picked up on several ultrasounds typical of a routine pregnancy. “His oxygen was very low. He was very purple and blue,… read on > read on >
A newly approved lung cancer drug shows promise in improving survival in patients whose tumors carry a common and tough-to-treat genetic mutation, researchers say. Sotorasib — brand name Lumakras — was approved May 28 by the U.S. Food and Drug Administration as a targeted therapy for non-small cell lung cancer patients with tumors that express… read on > read on >
After a diagnosis of breast cancer, Black women face a greater risk of having the disease spread to distant sites in the body — a disparity that is not readily explained, researchers say. It’s known that in the United States, Black women have the highest death rates from breast cancer of any racial or ethnic… read on > read on >
U.S. teens are getting their COVID shots — how does that change their daily lives? Besides letting teens resume many of their normal activities, U.S. authorization of the Pfizer COVID-19 vaccine for people as young as 12 is crucial to slowing the spread of the coronavirus, one expert says. “We know that teenagers can not… read on > read on >
In some good news for those who have already suffered through a bout of COVID-19, a new study finds they may have a much lower risk of reinfection for at least 10 months. For the study, the researchers analyzed rates of SARS-CoV-2 infections between October 2020 and February 2021 among more than 2,000 nursing home… read on > read on >
